Cancer Accelerated Approval On Trial: Advisors With Conflict-Of-Interest Waivers More Likely To Support Industry

 
• By Sarah Karlin-Smith
Scales with money and votes
ODAC panelists with conflict-of-interest waivers supported industry most of the time. • Source: Andrii Yalanskyi /Alamy Stock Photo

More from US FDA Performance Tracker

More from Regulatory Trackers